SLC16A1 and hepatocellular carcinoma: This oncogenic nature is further supported by the study of Duan et al. [99], which demonstrates that SLC16A1-AS1 modulates the miR-411/MITD1 axis, affecting HCC cell viability, proliferation, migration, and invasion.